NCT03188068View on ClinicalTrials.gov

Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Kaposiform HemangioendotheliomaKasabach Merritt Phenomenon
Interventions
DRUG

Sirolimus

Oral administration

DRUG

Prednisolone

Oral administered with sirolimus

Trial Locations (1)

610041

West China Hospital of Sichuan University, Chengdu

All Listed Sponsors
lead

West China Hospital

OTHER

NCT03188068 - Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma | Biotech Hunter | Biotech Hunter